SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-235408
Filing Date
2020-08-31
Accepted
2020-08-31 07:05:04
Documents
14
Period of Report
2020-08-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d75253d8k.htm   iXBRL 8-K 42020
2 EX-2.1 d75253dex21.htm EX-2.1 432502
3 EX-99.1 d75253dex991.htm EX-99.1 22971
  Complete submission text file 0001193125-20-235408.txt   732558

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ions-20200830.xsd EX-101.SCH 3060
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20200830_lab.xml EX-101.LAB 17373
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20200830_pre.xml EX-101.PRE 10946
7 EXTRACTED XBRL INSTANCE DOCUMENT d75253d8k_htm.xml XML 3272
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 201149772
SIC: 2834 Pharmaceutical Preparations